TY  - GEN
AU  - Burch,P A
AU  - Ghosh,C
AU  - Schroeder,G
AU  - Allmer,C
AU  - Woodhouse,C L
AU  - Goldberg,R M
AU  - Addo,F
AU  - Bernath,A M
AU  - Tschetter,L K
AU  - Windschitl,H E
AU  - Cobau,C D
TI  - Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial
SN  - 0277-3732
PY  - 2000///1026
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Dipyridamole
KW  - administration & dosage
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Leucovorin
KW  - Male
KW  - Middle Aged
KW  - Mitomycin
KW  - Pancreatic Neoplasms
KW  - drug therapy
KW  - Survival Analysis
KW  - Treatment Failure
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1097/00000421-200010000-00021
ER  -